Amarin Corporation plc (NASDAQ: AMRN) Q3 2020 earnings call dated Nov. 05, 2020 Corporate Participants: Elisabeth Schwartz -- Senior Director, Investor Relations John Thero -- President
Amarin Corporation plc
-(AMRN)
XNAS:AMRN
Amarin Corporation plc (AMRN) Q2 2020 Earnings Call Transcript
Amarin Corporation plc (NASDAQ: AMRN) Q2 2020 earnings call dated Aug. 04, 2020 Corporate Participants: Elisabeth Schwartz -- Senior Director of Investor Relations John
Amarin (AMRN) Q2 2020 earnings call: Focus was mainly on VASCEPA litigation
Amarin (NASDAQ: AMRN) reported second quarter 2020 results yesterday. During the earnings conference call, the management and the analysts discussed mainly the
Amarin (AMRN) maintains revenue growth despite COVID-19 headwinds
Amarin Corporation plc (NASDAQ:AMRN) reported second quarter 2020 earnings results today. The company reported a 34% growth in total revenue to $135.3
Amarin (AMRN) stock to remain within a tight range until the end of Vascepa litigation
The patent war between Amarin (NASDAQ: AMRN) and the generic companies for cardiovascular drug Vascepa continues to be a headwind for Amarin.
Amarin Corporation plc (NASDAQ: AMRN) Q1 2020 Earnings Call Transcript
Amarin Corporation plc (AMRN) Q1 2020 earnings call dated Apr. 30, 2020 Corporate Participants: Elisabeth Schwartz -- Senior Director of Investor Relations John F.
Amarin (AMRN) exploring use of VASCEPA in COVID-19-related cardiovascular risk reduction
Shares of Amarin Corporation plc (NASDAQ: AMRN) were up 4.6% in midday trade on Tuesday, a day after the company reported preliminary
Amarin Corporation plc (NASDAQ: AMRN) Q1 2020 Earnings Call Transcript
Amarin Corporation plc (AMRN) Q1 2020 earnings call dated Apr. 13, 2020 Corporate Participants: Elisabeth Schwartz -- Senior Director of Investor Relations John Thero -- President
Amarin Corporation plc (NASDAQ: AMRN) Q4 2019 Earnings Call Transcript
Amarin Corporation plc (NASDAQ: AMRN) Q4 2019 Earnings Conference Call February 25, 2020 Corporate participants: Elisabeth Schwartz -- Senior Director of Investor Relations John
Amarin Corporation (AMRN): Q4 2019 Earnings Snapshot
— Amarin Corporation plc (NASDAQ: AMRN) reported earnings of $0.04 per share in the fourth-quarter 2019 vs. $0.02 per share loss expected. — Revenue grew
New hope for investors as Amarin (AMRN) sees a promising year ahead
Though Amarin Corporation (NASDAQ: AMRN) has been showing signs of recovery since last year, after staying low for several years, the stock
Where is Amarin (AMRN) headed after FDA panel favors Vascepa’s label expansion?
Biotech firm Amarin Corporation (NASDAQ: AMRN) had a positive start to the week, with the shares making sharp gains and hitting the
Amarin’s Q3 results top estimates
Amarin Corporation plc (NASDAQ: AMRN) reported better-than-expected revenue and earnings for the third quarter of 2019, allowing the stock to gain 2%
4 biotech stocks that are ideal takeover targets
Speculation plays a big role when investing in biotech stocks, hence making them highly volatile. It could be after years of stock
Amarin’s stock gains on Q2 results beat
Amarin Corporation plc (NASDAQ: AMRN) reported better-than-expected revenue and earnings for the second quarter of 2019, allowing the stock to gain 2.2%
Amarin Corp tops the market in Q1 on Vascepa strength
Amarin Corporation (NASDAQ: AMRN) on Wednesday said its revenues soared 67% to $73.3 million, riding on the strong demand for its Vascepa
Amarin earnings preview: Expect higher revenues, but wider losses in Q1
Amarin Corporation (NASDAQ: AMRN) is scheduled to report first-quarter 2019 earnings results on Wednesday, May 1, before the opening bell. Analysts expect the
Why Amarin stock is rallying today
Amarin Corporation (NASDAQ: AMRN) shares got a major boost during the pre-market hours of Thursday after it said the American Diabetes Association
Amarin’s stock gains after Q4 revenues beat expectations
Amarin Corporation (AMRN) surpassed analysts’ expectations on revenues for the fourth quarter of 2018 while net loss came in higher-than-expected. Shares rose
Earnings preview: Amarin likely to deliver strong Q4 results
Amarin Corporation (AMRN) is scheduled to report earnings results for the fourth quarter of 2018 on Wednesday, February 27, before the market
Amarin shares jump 14% on rumors over Novartis interest
Shares of Amarin Corp (AMRN) gained up to 14% during the regular trading hours on Friday as rumors of an acquisition once